Cargando…
miR-429 inhibits osteosarcoma progression by targeting HOXA9 through suppressing Wnt/β-catenin signaling pathway
Osteosarcoma (OS) is the most commonly diagnosed malignant cancer of bone that occurs in adolescents and children. Mounting number of studies have indicated that miRNAs are increasingly playing fundamental roles in OS development. Thus, the biological function of miR-429 in OS progression was explor...
Autores principales: | Sun, Liangzhi, Wang, Libo, Luan, Suxian, Jiang, Yanzhou, Wang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399823/ https://www.ncbi.nlm.nih.gov/pubmed/32782562 http://dx.doi.org/10.3892/ol.2020.11766 |
Ejemplares similares
-
MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1
por: Deng, Yi, et al.
Publicado: (2017) -
MiR‐429 suppresses proliferation and invasion of breast cancer via inhibiting the Wnt/β‐catenin signaling pathway
por: Zhang, Liping, et al.
Publicado: (2020) -
MicroRNA-873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β-catenin pathway
por: Liu, Yilin, et al.
Publicado: (2022) -
MicroRNA-744 promotes carcinogenesis in osteosarcoma through targeting LATS2
por: Sun, Liangzhi, et al.
Publicado: (2019) -
MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9
por: Zhang, Zi-Feng, et al.
Publicado: (2017)